| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -54,638 |
| Depreciation and amortization | 387 |
| Accretion and amortization on investments, net | 5,477 |
| Amortization of debt issuance costs/debt discounts | 788 |
| Non-cash interest expense on liabilities for sales of future royalties | 15,043 |
| Stock-based compensation for services by non-employees | 70 |
| Stock-based compensation for employees and directors | 20,888 |
| Amortization of right-of-use assets | 542 |
| Increase in allowance for doubtful accounts | -4 |
| Inventory | 56,708 |
| Accounts receivable, net | -589 |
| Prepaid expenses, interest receivable and other assets | -167 |
| Current and noncurrent liabilities | -114 |
| Payment on royalty agreement | 10,503 |
| Net cash used in operating activities | -88,970 |
| Purchases of property and equipment | 49 |
| Purchases of marketable securities | 200,202 |
| Proceeds from maturities of marketable securities | 286,353 |
| Net cash provided by (used in) investing activities | 86,102 |
| Proceeds from issuances of common stock from equity plans | 1,389 |
| Proceeds from issuance of common stock from offering and pre-funded warrant, net of paid issuance costs | 0 |
| Proceeds from exercise of warrants | 0 |
| Proceeds from employee stock purchase plan | 500 |
| Net cash provided by financing activities | 1,889 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 96 |
| Net increase in cash, cash equivalents and restricted cash | -883 |
| Cash and cash equivalents at beginning of period | 80,876 |
| Cash and cash equivalents at end of period | 79,993 |
GERON CORP (GERNW)
GERON CORP (GERNW)